Actavis Group hf.
Overview
Actavis Group is a formidable player in the generic drug market. The company is one of the world's largest generic pharmaceuticals producers, with about 350 drugs in its development pipeline and some 800 products on the market across a variety of therapeutic classes (among them cardiovascular, gastrointestinal, and oncology). It also manufactures generic hospital products, including antibiotics, anesthetics, and painkillers. Actavis makes drugs in pill, liquid, injectable, suppository, and other forms. Subsidiary Medis distributes its drugs worldwide. Actavis, which was founded in 1956, is controlled by founder Thor Bjorgolfsson through his investment vehicle Novator.
Sample OverviewKey Numbers from Hoover's UK
Key financials for Actavis Group hf.
| Company Type | Private |
|---|---|
| Fiscal Year-End | December |
Key People from Hoover's UK
Key people and executives for Actavis Group hf.
| Deputy CEO | Gudbjorg Edda Eggertsdottir (Subscribers see complete biographies -- view sample)
|
|---|---|
| EVP Finance | Mark Keatley |
| EVP Human Resources and Organizational Development | Gunnar A. Beinteinsson |
Top Competitors from Hoover's UK
Top competitors of Actavis Group hf.
There are 19 competitors for Actavis; see more.Significant Developments
View company events at Actavis Group hf. such as IPOs, bankruptcies, or executive changes
| Event | Details |
|---|---|
| Address Change | Subscribers get full details -- view a sample |
| Top Executive Change | |
| Top Executive Change |
Industry Information from Hoover's UK
First Research Industry Profiles Extensive Industry Intelligence
Hoover's Industries
More Industry InformationSubsidiaries/Affiliates Covered By Hoover's UK
Subsidiaries/affiliates of Actavis Group hf.
